China Scraps Drug Price-Control System For More-Moderate Alternative
This article was originally published in PharmAsia News
Executive Summary
China plans to scrap its control of the prices of commonly used drugs because the system apparently has led to shortages, but seeks to replace it with one tied more to production cost and the market situation.